| Typicality: | 0.420 |
| Saliency: | 0.399 |
| to assess tolerability | 7 | purpose |
| primarily | 2 | degree |
| of srk-015 | 2 | other |
| trial → assess → pharmacodynamic | 22 |
| trial → evaluate → pharmacodynamic | 11 |
| trial → designed to assess → pharmacodynamic | 3 |
| negative | neutral | positive |
| 0.026 | 0.882 | 0.092 |
| Raw frequency | 36 |
| Normalized frequency | 0.399 |
| Modifier score | 0.500 |
| Perplexity | 234.999 |